Last reviewed · How we verify

NCT07087145

Feasibility of HPV Testing With Mail-delivered Sample Collection Kits

Recruiting now Last updated 1 August 2025
What this trial tests

trial testing Mail-based Saliva Sample Kit in HPV Infection in 135 participants. Currently enrolling.

Timeline
17 November 2024
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorUniversity of California, San Francisco
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment135
Start date17 November 2024
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

35 and older, any sex, with HPV Infection or HIV Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

People living with human immunodeficiency virus (PLWH) have an estimated 1.6-6.0 times increased risk of developing oropharyngeal cancer (OPC) compared with individuals in the general population. 70% of OPCs are caused by human papillomavirus (HPV), and PLWH also have an increased prevalence of oral HPV infection. Disparities by race/ethnicity also include a later stage of diagnosis and less frequent cancer-directed treatment for members of ethnic minority groups. There is little known regarding the racial/ethnic differences in oral HPV infection, persistence of oral HPV infection, or progression of oral HPV infection to OPC among PLWH. This is an observational, prospective cohort study to investigate the feasibility of alternative sample collection methods for HPV testing among PLWH.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for HPV Infection

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07087145.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing